Latest Series C+ Funding Rounds

Later-stage rounds, from Series C onwards, for companies expanding products, distribution and operations.

This page showsStage: Series C+
Rounds
572
All time
Disclosed funding
$283.5B
494 disclosed amounts
Median round
$126M
Of disclosed amounts
572 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
AutomataIndustrial tech · United KingdomCompany profile

Builds AI-ready lab automation platforms for life sciences

Builds AI-ready lab automation platforms for life sciences

$45MSeries CSeries C+Industrial techUnited KingdomInvestors
DecagonEnterprise software · United StatesCompany profile

Provides conversational AI agents for concierge customer experiences

Provides conversational AI agents for concierge customer experiences

$250MSeries DSeries C+Enterprise softwareUnited StatesInvestors
WaabiMobility · CanadaCompany profile

Waabi develops AI-powered autonomous driving technology for trucking.

Waabi develops AI-powered autonomous driving technology for trucking.

$750MSeries CSeries C+MobilityCanadaInvestors
CellaresBiotech · United StatesCompany profile

Cellares manufactures cell therapies for drug developers using automated production and quality-control systems deployed through its Smart Factory network.

Cellares manufactures cell therapies for drug developers using automated production and quality-control systems deployed through its Smart Factory network.

$257MSeries DSeries C+BiotechUnited StatesInvestors
Redwood MaterialsClimate tech · United StatesCompany profile

Recycles batteries and produces cathode materials for energy storage

Recycles batteries and produces cathode materials for energy storage

$425MSeries ESeries C+Climate techUnited StatesInvestors
MeshFintech · United StatesCompany profile

Builds the universal crypto payments network

Builds the universal crypto payments network

$75MSeries CSeries C+FintechUnited StatesInvestors
AntheiaBiotech · United StatesCompany profile

Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients.

Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients.

$24MSeries C second closeSeries C+BiotechUnited StatesInvestors
Fiddler AIAI · United StatesCompany profile

Provides AI observability and security platform for enterprises

Provides AI observability and security platform for enterprises

$30MSeries CSeries C+AIUnited StatesInvestors
SynthesiaAI · United KingdomCompany profile

Develops AI-powered digital avatars for corporate clients

Develops AI-powered digital avatars for corporate clients

$200MSeries ESeries C+AIUnited KingdomInvestors
Cyclic MaterialsClimate tech · CanadaCompany profile

Recycles rare earth elements from end-of-life products and magnet production waste

Recycles rare earth elements from end-of-life products and magnet production waste

$75MSeries CSeries C+Climate techCanadaInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    Andreessen Horowitz (a16z)

    Isomorphic Labs, Northwood Space, Kalshi

    44rounds
    5led
  2. 2
    General Catalyst

    Mercor, Clara, Nominal

    44rounds
    1led
  3. 3
    Sequoia Capital

    Isomorphic Labs, LangChain, Nominal

    43rounds
    8led
  4. 4
    Lightspeed

    Payhawk, Nominal, Fractile

    39rounds
    7led
  5. 5
    NVIDIA

    Agile Robots, Mercor, fal

    36rounds
    0led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic